Back to News & Events

Hepatitis C Portfolio Launch May 2018

Aspin Pharma continues to strive for excellence. With every passing year, we pledge to get better and more efficient with introducing new products and expanding our horizons in order to ultimately become the number one pharmaceutical company.

In 2018, Aspin Pharma launched Hepatitis C portfolio including three products, namely; Sofvel, Sofhep and Dasavir.